vytaros 2 mg/g krem
recordati ireland limited - alprostadilum - krem - 2 mg/g
pikopil 7,5 mg tabletki
farmak international sp. z o.o. - natrii picosulfas - tabletki - 7,5 mg
coripren 10 mg + 10 mg tabletki powlekane
recordati ireland limited - lercanidipini hydrochloridum + enalaprili maleas - tabletki powlekane - 10 mg + 10 mg
coripren 20 mg + 20 mg tabletki powlekane
recordati ireland limited - enalaprili maleas + lercanidipini hydrochloridum - tabletki powlekane - 20 mg + 20 mg
vytaros 3 mg/g krem
recordati ireland limited - alprostadilum - krem - 3 mg/g
pikopil 7,5 mg/ml krople doustne, roztwór
farmak international sp. z o.o. - natrii picosulfas - krople doustne, roztwór - 7,5 mg/ml
aurelit 70 wg
adama deutschland gmbh edmund - rumpler strasse, 51149 klonia, republika federalna niemiec - metrybuzyna - metrybuzyna - 700 g - chwastobójczy
mistral 70 wg
adama deutschland gmbh edmund - rumpler strasse, 51149 klonia, republika federalna niemiec - metrybuzyna - metrybuzyna - 70 % - chwastobójczy
raba 70 wg
adama deutschland gmbh edmund - rumpler strasse, 51149 klonia, republika federalna niemiec - metrybuzyna - metrybuzyna - 700 g - chwastobójczy
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - karmustinom - hodgkin disease; lymphoma, non-hodgkin - Środki przeciwnowotworowe - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).